A. E. Lacerda

发表

Molecular characterization of a neuronal low-voltage-activated T-type calcium channel

Jung-Ha Lee, E. Perez-Reyes, L. Cribbs, 1998, Nature.

Pathways of HERG inactivation.

A. Brown, A. E. Lacerda, J. Kiehn, 1999, American journal of physiology. Heart and circulatory physiology.

Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern.

A. Brown, G. Kirsch, A. E. Lacerda, 2004, Journal of pharmacological and toxicological methods.

Comparison of block among cloned cardiac potassium channels by non-antiarrhythmic drugs

James Kramer, Arthur M. Brown, D. Thomas, 2001 .

A new site for the activation of cardiac calcium channels defined by the nondihydropyridine FPL 64176.

A. E. Lacerda, D. Rampe, 1991, The Journal of pharmacology and experimental therapeutics.

T-type and N-type calcium channels of Xenopus oocytes: evidence for specific interactions with beta subunits.

A. Brown, E. Perez-Reyes, A. E. Lacerda, 1994, Biophysical journal.

Normalization of current kinetics by interaction between the alpha 1 and beta subunits of the skeletal muscle dihydropyridine-sensitive Ca2+ channel.

A. Brown, F. Hofmann, V. Flockerzi, 1991, Nature.

Interactions of the nonsedating antihistamine loratadine with a Kv1.5-type potassium channel cloned from human heart.

A. E. Lacerda, D. Rampe, M. Roy, 1997, Molecular pharmacology.

Modification of Ca2+ channel activity by deletions at the carboxyl terminus of the cardiac alpha 1 subunit.

E. Stefani, R. Olcese, L. Birnbaumer, 1994, The Journal of biological chemistry.

Cloning and expression of a cardiac/brain beta subunit of the L-type calcium channel.

L. Birnbaumer, E. Perez-Reyes, A. E. Lacerda, 1992, The Journal of biological chemistry.

Oral Vanoxerine Prevents Reinduction of Atrial Tachyarrhythmias: Preliminary Results

A. Brown, A. Waldo, K. Ryu, 2011, Journal of cardiovascular electrophysiology.

Endothelin increases single‐channel calcium currents in coronary arterial smooth muscle cells

S. Silberberg, A. E. Lacerda, T. Poder, 1989, FEBS letters.

[3H]PN200-110 binding in a fibroblast cell line transformed with the alpha 1 subunit of the skeletal muscle L-type Ca2+ channel.

A. Brown, L. Birnbaumer, A. E. Lacerda, 1990, Biochemical and biophysical research communications.

Na and Ca Channels in the Heart

A. Brown, D. Kunze, A. E. Lacerda, 1987 .

Effects of protein kinase C activators on cardiac Ca2+ channels

A. Brown, A. E. Lacerda, D. Rampe, 1988, Nature.

Activity-dependent scaling of quantal amplitude inneocortical neurons

Jane Barclay, Jung-Ha Lee, E. Perez-Reyes, 2022 .

Induction of calcium currents by the expression of the α1-subunit of the dihydropyridine receptor from skeletal muscle

A. Brown, K. Campbell, L. Birnbaumer, 1989, Nature.

Vanoxerine: Cellular Mechanism of a New Antiarrhythmic

Y. Kuryshev, A. Brown, A. Waldo, 2010, Journal of cardiovascular electrophysiology.

Normalization of current kinetics by interaction between the α1and β subunits of the skeletal muscle dihydropyridine-sensitive Ca2+ channel

A. Brown, F. Hofmann, V. Flockerzi, 1991, Nature.

Cloning and Expression of a Novel Member of the Low Voltage-Activated T-Type Calcium Channel Family

Jung-Ha Lee, T. Schneider, E. Perez-Reyes, 1999, The Journal of Neuroscience.

Alfuzosin Delays Cardiac Repolarization by a Novel Mechanism

Tianen Yang, James W Kramer, Y. Kuryshev, 2008, Journal of Pharmacology and Experimental Therapeutics.

Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).

F. Liu, R. Bridges, A. E. Lacerda, 2017, Journal of medicinal chemistry.

Vanoxerine, a New Drug for Terminating Atrial Fibrillation and Flutter

A. Brown, A. Waldo, K. Ryu, 2010, Journal of cardiovascular electrophysiology.

Variability of the QTc interval: impact on defining drug effect and low-frequency cardiac event.

D L Kunze, W. Crumb, A. Brown, 1993, The American journal of cardiology.

The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes.

A. Bruening-Wright, A. Brown, G. Kirsch, 2010, Journal of pharmacological and toxicological methods.

Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide.

A. Brown, A. Brown, B. Wible, 1996, Circulation.

Cardiac Na currents and the inactivating, reopening, and waiting properties of single cardiac Na channels

D L Kunze, A E Lacerda, D L Wilson, 1985, The Journal of general physiology.

Parathyroid hormone: An endogenous modulator of cardiac calcium channels

A. Brown, A. E. Lacerda, D. Rampe, 1991 .

Neurotoxins That Act Selectively on Voltage‐Dependent Cardiac Calcium Channels

A. Brown, L. Possani, A. E. Lacerda, 1987, Circulation research.

Heterologous regulation of the cardiac Ca2+ channel alpha 1 subunit by skeletal muscle beta and gamma subunits. Implications for the structure of cardiac L-type Ca2+ channels.

A. Brown, L. Birnbaumer, E. Perez-Reyes, 1991, The Journal of biological chemistry.

Nonmodal gating of cardiac calcium channels as revealed by dihydropyridines

A. Brown, A. E. Lacerda, A. M. Brown, 1989, The Journal of general physiology.

Mapping the block of a cloned human inward rectifier potassium channel by dofetilide.

A. Brown, B. Wible, A. E. Lacerda, 1996, Molecular pharmacology.

Parathyroid hormone: an endogenous modulator of cardiac calcium channels.

A. Brown, A. E. Lacerda, D. Rampe, 1991, The American journal of physiology.

Pathways of HERG inactivation.

A. Brown, A. E. Lacerda, J. Kiehn, 1999, The American journal of physiology.

Oral Vanoxerine Prevents Reinduction of Atrial Tachyarrhythmias: Preliminary Results

A. Brown, A. Waldo, K. Ryu, 2011, Journal of cardiovascular electrophysiology.